SlideShare una empresa de Scribd logo
1 de 47
Seminar presentation

Principles of Topical Therapy

Moderator:- Dr. R. S. Meena
• The skin has a surface area of 1.6-2 m2
• This area enables the enhancement of
systemic treatment measures
• An extensive region for the application and
absorption of topical medications
• The active ingredients penetrate the skin
either via transepidermal or transfollicular
pathways
• Sensible topical drug therapy involves not only the selection of an
appropriate agent, but also a thoughtful consideration of the areas
of the body affected.
• Basic principles1. State of the diseased skin(Pathologic changes)
2. Age of patient
3. Area of the body
4. Concentration of the drug
5. Type of vehicle (e.g., ointment, cream, lotion)
6. Method of application
7. A defined duration of use that both maximizes efficacy and
minimizes adverse side effects.
FACTORS THAT AFFECT ABSORPTION
CUTANE
OUS
DRUG
DELIVERY

Therapeutic efficacy-relates to both its inherent potency and its ability
to penetrate the skin. Percutaneous absorption necessitates passage
through the stratum corneum, epidermis, papillary dermis, and into
the bloodstream. Topical medicines generally have a poor total
absorption . But it does not necessarily translate into low efficacy.

Stratum Rate-limiting barrier to percutaneous drug delivery. Composed of
Corneum ceramides, free fatty acids, and cholesterol in a 1:1:1 molar ratio and
By weight 50%, 35 % and 15% respectively. Drug penetration, will vary
depending on body site, due to its thickness. Diseased skin- Abraded
or eczematized skin presents less of a barrier.
Solvents, surfactants, and alcohols can denature the cornified layer
and increase penetration
Occlusio
n

Range from application under an airtight dressing such as vinyl gloves
or plastic wrap, to occlusion with cotton gloves or socks at night for
treatment of hands and feet, to application of a medication already
impregnated into an airtight dressing, as seen in flurandrenolide
(Cordran) tape.
Greatest benefit-should hydrate the skin by immersion in water.
It increased- both efficacy and side effects .
•
•
•
•
•
•
•
•
•
•
•

Regional Differences in Penetration in decreasing orders
1.Mucous membrane
2. Scrotum
3. Eyelids
4. Face
5.Chest and back
6.Upper arm and legs
7.Lower arm and legs
8.Dorsa of hand and feets
9.Palmer and planter skin
10.Nails
Frequency of Application
• Must be specified in order to maximize the response whilst
avoiding side effects such as irritation.
• Emollients should be applied frequently enough to maintain
their physical effect.
• Active preparations are usually applied just once or twice a
day.
• As a general rule, twice daily application of drugs such as
corticosteroids or deltanoids is only marginally more effective
than once daily application.
• Increasing the interval between applications can be a useful
method of gradually reducing the intensity of a
treatment, especially when it is difficult to do so by using a
lower concentration or less potent agent.
Drug concentration
• The concentration is usually written as a percentage
representing the proportion of the formulation, by weight,
which is the active constituent.
• A concentration of 1% indicates that 1 g of drug will be
contained in 100 g of the formulation.
• 1% solution contains 1 g of drug in 100 ml of the formulation.
• Abbreviations w/w (weight in weight) and w/v (weight in
volume) are often employed to indicate which convention is
being used.
• Concentration of a solution is in ‘parts’; thus a 1 part in 1000
solution of potassium permanganate contains 1 g in 1 L of
solution, which could be expressed as 0.1% (w/v).
Quantity of Application
• The total quantity to be dispensed should be specified and it
is helpful to inform the patient how long the prescribed
quantity is expected to last.
• Estimates of the quantity of cream or ointment have varied.
• In one study a range of 12–27 g (average 18 g) was required
for applications by ‘trained operators’, whilst a range of 8–115
g (average 44 g) was required when the treatment was self
administered.
• In a more recent study, male patients treating themselves
applied an average of 20 g of ointment, and females applied
17 g.
• Quantity required for 1 week of once-daily application to the
whole body would be approximately 140 g for males and 120
g for females.
Quantities (g) of medication required for twice daily
application to the entire body at various ages.
Age

Requirement
Daily (g) 8

Weekly (g)

3 months

8

56

6months

10

67

12 months

12

84

18 months

13

93

2 years

14

95

3 years

16

112

4 years

19

135

5 years

20

140

7 years

25

172

10 years

30

210

12 years

37

256
Approximate quantities (g) required for each application of
Medication to different anatomical regions.
Anatomical region

Males

Females

Trunk (including buttocks)

6.6

5.8

One leg

2.9

2.5

One foot

0.9

0.7

One arm and forearm

1.7

1.3

One hand

0.6

0.5

Face, neck and ears

1.3

0.9

Whole body

20

17
Fingertip unit- An approximate but practical measure of
topical medication is the fingertip unit.
•This is the quantity of ointment, extruded from a tube with
a nozzle of 5 mm diameter (note that nozzles do vary
somewhat), extending from the distal crease of the
forefinger to ventral aspect of the fingertip.
fingertip unit
•This unit weighs approximately 0.49 g in males and 0.43 g in
females and covers, on average, an area of approx 300 cm2.

The fingertip unit.
Fingertip units required for a single treatment of various
regions in children and adults adapted from. The unit is
measured using an adult finger.
Age

Face and One upper One lower Trunk
neck
limb
limb

Whole body

3–6 month

1

1

1.5

2.5

8.5

1–2 years

1.5

1.5

2

5

13.5

3–5 years

1.5

2

3

6.5

18

6–10 years

2

2.5

4.5

8.5

24.5

Adult

2.5

4.5

7.6

13.5

40
Compliance
• Generally, adherence to a treatment regimen is associated
with female gender, employment, being married, and low
prescription costs.
• Lower adherence is seen for patients with extensive
disease, and paradoxically, Disease on the face.
• Furthermore, compliance is negatively affected by
depression, which is common in people with chronic skin
conditions and found in up to 20 percent of patients with
psoriasis.
Miscellaneous Factors
• Vigorous rubbing or massaging of the drug -increases the
surface area and blood supply to the area locally, augmenting
systemic absorption .
• Presence of hair follicles on a particular body site also
enhances drug delivery with the Scalp and beard areas
presenting less of a barrier when compared with the relatively
Hairless body sites.
• Skin of older individuals is poorly hydrated, with fewer hair
follicles and therefore may impede drug delivery.
• Reducing the particle size of the active ingredient increases its
surface area-volume ratio, allowing for a greater solubility of
the drug in its vehicle.
CLASSIFICATION AND CLINICAL APPLICATION
OF TOPICAL FORMULATIONS
• The vehicle is the inactive part of a topical preparation that
brings a drug into contact with the skin.
• Beneficial non-specific effectsCooling, protective, emollient, occlusive, or astringent
properties.
• Functions optimally when it is stable both chemically and
physically and does not inactivate the drug.
• It also should be nonirritating, nonallergenic, cosmetically
acceptable, and easy to use.
• Additionally, the vehicle must release the drug into the
pharmacologically important compartment of the skin.
• Finally, the patient must accept using the vehicle or else
compliance will be poor.
Frequently employed constituents of vehicles
Lipids

Castor oil, Cetyl alcohol, Cocoa butter, Isopropyl myristate,
Isopropyl palmitate, Lanolin, Liquid paraffin, Shea butter, Stearic acid,
Stearyl alcohol, White soft paraffin (petrolatum)

Emulsifiers

Alkyl sulphates and sulphonates, Glyceryl monostearate, Lanolin and
derivatives, Phosphoric acid esters, Polyethylene glycols, Polyvalent
metallic soaps, Propylene glycol fatty acid esters, Quaternary
ammonium cationic compounds, Sorbitan monolaurate,
monopalmitate and mono-oleate, Triethanolamine oleate

Humectants

Gelatine, Glycerin, Propylene glycol, Pyrrolidone carboxylic acid,
Sorbitol, Urea

Penetration
enhancers

Azone, Dimethyl sulphoxide, Propylene glycol, Salicylic acid, Urea

Preservative
s

Benzyl alcohol, Butylated hydroxyanisole, Butylated hydroxytoluene
Chlorocresol, Edetic acid/disodium edetate, Hydroxybenzoates
(parabens), Propylene glycol, Sodium metabisulphite, Sorbic
acid/sorbates

Solvents

Acetone, Ethanol, Ether, Chloroform, Glycerin, Isopropyl alcohol
Methanol, Propylene glycol, Water
Powders

Absorb
moisture and
decrease
friction

Used in the
intertriginous areas
and on the feet
Eg. antifungals

Contain zinc oxide eg. calamine
(antiseptic and covering
properties), talc (lubricating and
drying properties), and stearate
(improved adherence)

Poultices Wet solid mass
(cataplasm of particles,
)
sometimes
heated, that is
applied to
diseased skin

Used as wound
cleansers and
absorptive agents in
exudative lesions
such as decubiti and
leg ulcers.

Historically, contained meal,
herbs, plants, and seeds. Modern
poultice often consists of porous
beads of dextranomer.

Ointments Semisolid
preparations
that spread
easily.

Protective, hydrating, Classified into five categories:
and lubricating.
Hydrocarbon bases,
Absorption bases,
Emulsions of water-in-oil,
Emulsions of oil-in-water, and
Water-soluble bases.

Dermatologists commonly refer to the hydrocarbon bases and absorption bases as
ointments and the water-in-oil/oil-in-water emulsion bases as creams.
In pharmaceutical terms, all of these preparations are ointments.
HYDR0CARB0N
BASES
(oleaginous
bases)

Composed of a
mixture of
hydrocarbons of
varying
molecular
weights, m.c.
petrolatum

Greasy and can
stain clothing.
stable and do not
contain
preservatives.
not used for watersoluble drugs.

silicon ointments are
composed of alternating
oxygen and silicon atoms
bonded to organic groups,
such as phenyl or methyl,
and are excellent skin
protectants.

ABSORPTI0N
BASES

Contain
hydrophilic
substances that
allow for the
absorption of
water-soluble
drugs.

Lubricating and
hydrophilic, can
form emulsions.
Function as
emollients and
protectants

Greasy but easier to
remove, do not contain
water.
Eg. anhydrous lanolin and
hydrophilic petrolatum.
CREAMS(
WATERIN-0IL
EMULSIO
N)

By definition,
contains <25%
water, with oil
being the
dispersion
medium.
two-phase
systems may
separate
unless shaken

Less greasy,
spread easily,
and provide a
protective film
of oil, slow
evaporation of
the water phase
provides a
cooling effect

Emulsifier( or surfactant) is soluble in
both phases and surrounds the dispersed
drops to prevent their coalescence.
Preservatives are frequently added to
increase the emulsion's shelf life.
Eg. surfactants- sodium lauryl sulfate, the
quaternary ammonium Compounds,
Spans( sorbitan fatty acid esters), and
Tweens (polyoxyethyiene sorbian fatty
acid esters).

Oil-inwater
Emulsion
s

Contains >31
% water.
Contain
preservatives,
such as the
parabens, to
inhibit the
growth of
molds.

Spread very
easily, are water
washable and
less greasy, and
are easily
removed from
the skin and
clothing.

Contain a humectant (an agent that
draws moisture into the skin), such as
glycerin, propylene glycol, or
polyethylene glycol(PEG), to prevent the
cream from drying out.
oil phase may contain either cetyl or
stearyl alcohol (paraffin alcohols) to
impart a stability and velvety smooth feel
upon application to the skin.
Water- Consist either primarily Water soluble,
require no
soluble or completely of
various PEGs.
preservative
bases
Depending on their
M.W., PEGs are either
liquid (eg. PEG 400) or
solid (PEG 4000).

Gels

additives.
nonstaining,
greaseless, and
easiiy washed off
of the skin

Made from watersoluble bases by
formulating water,
propylene glycol,
and/or PEGs with a
cellulose derivative or
carbopol. Newer gel
contain the humectant
glycerin, the emollient
dimethicone, or the
viscoelastic
polysaccharide
hyaluronic acid

Clear and ease of
both application
and removal.
Easy to use on the
hair-bearing body
sites

It will be useful in scenarios
where the practitioner desires
a high surface concentration
and low percutaneous
absorption of the drug. e.g.
topical antifungal and
antibiotics (mupirocin).
They lack any protective or
emollient properties.
If they contain high
concentrations of alcohol or
propylene glycol, they tend to
be drying or cause stinging.
Gels require preservatives.
After application the aqueous
or alcoholic component
evaporates, and the drug is
deposited in a concentrated
form.
Pastes

High concentrations
of powders (up to 50
%) into an ointment
such as a
hydrocarbon base or
a water-in-oil
emulsion

Must be insoluble in
the ointment.
Stiffer than the
original ointment.
Commonly used are
zinc oxide, starch,
calcium carbonate,
and talc.

Solution

Dissolution of two or Liquid vehicle may be
more substances into aqueous,
homogenous clarity hydroalcoholic, or
non-aqueous
(alcohol, oils, or
propylene glycol).

Liniment
s

Non-aqueous
solutions of drugs in
oil or alcoholic
solutions of soap.

Function- localize the effect
of a drug that may be staining
or irritating (i.e. anthralin).
Impermeable barriers that
serve as protectants or
sunblocks.
Less greasy than ointments,
more drying, and less
occlusive.
Aqueous solution- aluminum
acetate or Burow's solution.
Hydroalcoholic solution with
50% alcohol is called a
tincture.

Base of oil or soap
Used as counterirritants,
facilitates application astringents, antipruritics,
to the skin with
emollients, and analgesics.
rubbing or massage.
Coliodion

Non-aqueous solution Flexible collodions have added castor oil
of pyroxylin in a
and camphor and are used, eg. to deliver
mixture with ether and 10% salicylic acid as a keratolytic agent.
ethanol
applied to the skin
with a soft brush

Suspension Two-phase system
or Lotion
consisting of a finely
divided, insoluble drug
dispersed into a liquid
in a concentration of
up to 20%.

Eg. calamine lotion, steroid lotions, and
emollients containing urea or lactic acid
easier to apply and allow for uniform
coating of the affected area, and are often
the favorite preparation in treating
children. more drying than ointments.

Shake
lotions

Application of shake lotions effectively dries
and cools wet and weeping skin.
consist of zinc oxide, talc, calamine,
glycerol, alcohol, and water, to which
specific drugs and stabilizers may be added.

Powder is added to
Lotions to increase the
surface area of
evaporation
Aerosols

Formulating the drug in
a solution within a pure
propellant. Propellant is
a blend of nonpolar
hydrocarbons.

Used to deliver drugs formulated as
solutions, suspensions, emulsions,
powders, and semisolids. applied to
abraded or eczematized skin, aerosols lack
the irritation of other formulations.

Aerosol
foams

Contains the drug within
an emulsion formulated
with a foaming agent(a
surfactant),
A solvent system (such
as water and ethanol),
and a propellant.

Used to deliver corticosteroids such as
betamethasone valerate and clobetasol
propionate.
On application, a foam lattice forms
transiently until it is broken by both the
heat of the skin and the heat of rubbing the
foam onto the skin.

Thickening Increase the viscosity of
agents
products or suspend
ingredients in a
formulation

Eg. beeswax and carbomers. Addition to
functioning as an ointment vehicle,
petrolatum may be added to an emulsion
to increase its viscosity. Ingredient ay have
a therapeutic effect as well as acting as part
of a vehicle.
Stabilizers
• Non-therapeutic ingredients and include the preservatives,
antioxidants, and chelating agents.
• Preservatives protect the formulation from microbial
growth.
• The ideal preservative is effective at a low concentration
against a broad spectrum of organisms, nonsensitizing,
odor free, color free, stable, and inexpensive.
• Unfortunately, the ideal preservative does not exist.
• The parabens are the most frequent added preservatives,
and are active against molds, fungi, and yeasts, but less
effective against bacteria.
• Alternative agents include the halogenated phenols,
benzoic acid, sodium benzoate, formaldehyde, the
formaldehyde-releasing agents, and previously, thimerosal.
• Most commonly used preservatives may act as contact
sensitizers.
• Antioxidants or preservatives prevent the drug or vehicle
from degrading via oxidation.
• Examples include butylated hydroxyanisole and burylated
hydroxytoluene, used in oils and fats.
• Ascorbic acid, sulfites, and sulfur-containing amino acids
are used in water soluble phases.
• Chelating agents, such as sodium EDTA and citric acid, work
synergistically with antioxidants by complexing heavy
metals in aqueous phases.
When do we use topical treatment?
• If a patient has a skin disorder covering <
30% of body, the topical medication
may be considered.
Choice of vehicles
• Three main determinants to choose the right
vehicle are:
Patient’s skin type
Degree of acuity of the disease
Nature of the lesions
Choice of vehicles
• Skin type: About 50% of individuals have oily skin
or seborrhea.
• They do better with creams, lotions, or shake
lotions while the ones with dry skin do better
with ointments or pastes.
• Degree of acuity: Acute inflammatory processes
are best treted with creams or lotions.
• If the lesions are weeping, shake lotions are fine.
Choice of vehicles for different lesions
Topical agents Ⅰ
Classification

Action

Smooth agents

reduce friction
avoid stimulation

Antimycotics

Antiseptics

Drug

Concentration(%)

calamine
talc
zinc oxide
kill or inhibition
sulphur
Glacial Acetic Acid
benzonic acid
salicylic acid
clotrimazole
Miconazole
Terbinafine
kill or inhibition
boracic acid
potassium
permanganate
Neomycin
revanol

10-15
10-70
20-50
5—10
5--30
6--12
5--10
2---3
2
1
3---4
1/2000
1/5000
0.5-1
0.1
Topical agents Ⅱ
Classification
Antipruritics

Action
narcotism、
dimimish inflammation
stop itchness

Drug

Concentration(%)

cool
mint

carbolic acid
bendazolecain
dexamethasone
triamcinolone
Keratoplastics promote normal keratosis
pityrol
shrink blood vessel
coal tar
reduce effusion and
resorcinol
inflammatory infiltration
salicylic acid

1---5
0.2-3
1---2
3---5
0.025
0.025
3---5
5--40
2---5
3
Topical agents Ⅲ
Classification
Action
Concentration(%)
keratolytics

Drug

hyperkeratosis
salicylic acid
make keratinocytes loose resorcinol
separate and fall off
Glacial Acetic Acid
urea
Caustics
remove granulation
carbolic acid
tissue and neoplasm
Glacial Acetic Acid
salicylic acid
trichloroaceticacid
sunscreen absorb or prevent
Titanium dioxide
ultraviolet radiation
depigmenting reduce pigmentation
Hydroquinone
agents
Azelaic Acid

6--15
6--15
10-30
20-40
pure
>30
>20
>30
5

3
20
Topical corticosteroids
Potency
Ultra high

Class

Formulation

II

Clobetasol propionate

Cream, 0.05%

Diflorasone diacetate
High

I

Topical corticosteroid

Ointment, 0.05%

Amcinonide

Ointment, 0.1%

Betamethasone dipropionate Ointment, 0.05%
Desoximetasone
Fluocinonide

Cream, ointment or gel,
0.05%

Halcinonide
III

Cream or ointment, 0.025%

Cream, 0.1%

Betamethasone dipropionate Cream, 0.05%
Betamethasone valerate

Ointment, 0.1%

Diflorasone diacetate

Cream, 0.05%

Triamcinolone acetonide

Ointment, 0.1%
Moderate

IV

Ointment, 0.2%

Triamcinolone acetonide

Cream, 0.1%

Betamethasone dipropionate

Lotion, 0.02%

Betamethasone valerate

Cream, 0.1%

Fluocinolone acetonide

Cream, 0.025%

Fludroxycortide

Cream, 0.05%

Hydrocortisone butyrate

Cream, 0.1%

Hydrocortisone valerate

Cream, 0.2%

Betamethasone valerate

Lotion, 0.05%

Desonide

Cream, 0.05%

Fluocinolone acetonide
VII

Ointment, 0.05%

Hydrocortisone valerate

VI

Ointment, 0.025%

Fludroxycortide

Low

Cream, 0.05%

Fluocinolone acetonide

V

Desoximetasone

Solution, 0.01%

Dexamethasone sodium phosphate Cream, 0.1%
Hydrocortisone acetate

Cream, 1%

Methylprednisolone acetate

Cream, 0.25%
Side effects of topical corticosteroids
•
•
•
•
•

Epidermis : Atrophy
Hair follicles: Steroid acne
Dermis: Atrophy, striae
Pigmentation: Hypopigmentation
Vessels: Erythema, telangiectases
Hazards associated with topical
treatment
• M.C. - Localized irritant or allergic reactions.
• This can be minimized by applying treatment at the optimal
concentration and treatment intervals and by selection of the
correct vehicle.
• Sensitization is more difficult to anticipate and to prevent.
• Contact allergy can develop not only to the active
medicament but also to constituents of the vehicle.
• Almost any component may sensitize; notable examples
include ethylenediamine, propylene glycol, emulsifiers, sorbic
acid , cetyl and stearyl alcohols and fragrances.
• Patients with chronic venous eczema or leg ulcers appear to
be particularly susceptible.
Systemic Side Effects
• Rare
• Absorption varies very considerably depending on the region
of skin being treated.
• Occlusion greatly enhances absorption.
• Systemic exposure can be greater than expected in children
due to their relatively high ratio of skin surface to body mass.
• In the elderly, penetration of drugs may be increased as a
result of changes in the structure of the skin.
• This effect is most pronounced in drugs which are most
hydrophilic .
• Inflammation of the skin impairs barrier function and
significantly increases drug absorption.
• This is especially significant in the erythrodermic patient
•Thanks
Topical agents
•
•
•
•
•
•
•
•
•

Keratolytic agents
Cytotatic agents: Podophyllin, 5-fluorouracil
Retinoids
Antibiotics, antifungals, antiviral agents
Corticosteroids
Combination products
Tacrolimus, pimecrolimus
Nonsteroidal antiinflammatory agents
Sunscreens
• Class I (weakest):
Hydrocortisone, prednisolone
• Class II: Methylprednisolone
aceponate, triamcinolone
• Class III: Betamethasone 17-valerate
• Class IV (strongest): Clobetasol 17-propionate
Formulation Ⅰ
Dosage form
Powder

Solution

Lotion

Cream

component

action

indications

drug put into
zinc oxide, talc
and stearate

Absorb moisture
acute and subacute inflammation
and decrease friction
but no effusion
astringency, protection, cooling
Used in the intertriginous areas and
on the feet Eg. antifungals
liquid and soluble drug cooling, clear raw surface 、 acute inflammation
dissolution of two or
reduce inflammation
with lots of effusion
more substances into eg. Aqueous solutionhomogenous clarity
aluminum acetate or Burrow’s solution
powder and liquid
protection, cooling
acute and subacute
mixture- two phase
reduce inflammation
inflammation without
system (conc. Up to 20%) astringency, more drying
effusion, favourite for
Eg. Calamine , steroid lotions,
children
emolient containing urea or lactic acid
consisting of aqueous
protection、lubrication
subacute or chronic
and oily components
intenerate crust
inflammation ,pruritus
O/W emulsion being readiy reduce inflammation
diluted with water,W/O
emulsion with oil Solution
Formulation Ⅰ
Dosage form
Gel
•

component

action

indications

Propanediol gelatin protection, lubrication subacute or chronic
of organic polymer reduce inflammation
inflammation ,pruritus
drug
Clear and ease of both
application and removal.
Easy to use on the
hair-bearing body sites
Fomulation Ⅱ
action

dosage form component
Paste

indications

cream including protection、astringency
25%-50% powder
intenerate crust
diminish inflammation

ointment vehicle with vaseline

or lanolin

strong action of
lubrication、penetration
intenerate crust

tincture resolve or steep

diminish inflammation

drug by alcohol
antipruritic

subacute inflammation,
scar,erosion

chronic inflammation
ulcer

chronic inflammation

sterilization
pruritus
Fomulation Ⅱ
dosage form

Plastics

component

action

organic menstruum
and aqueous solution
contain macromolecule
compound or film agent

indications

protection
strong percutaneous
strong percutaneous
action

chronic
inflammation

Más contenido relacionado

La actualidad más candente

Topical Prepartions in dermatology
Topical Prepartions in dermatologyTopical Prepartions in dermatology
Topical Prepartions in dermatologyDr. Saba Niyazee
 
Basic Pathological Reactions of the Skin - Dr Zainab Almossalli
Basic Pathological Reactions of the Skin - Dr Zainab AlmossalliBasic Pathological Reactions of the Skin - Dr Zainab Almossalli
Basic Pathological Reactions of the Skin - Dr Zainab Almossalliaskadermatologist
 
Disorders of pigmentation
Disorders of pigmentationDisorders of pigmentation
Disorders of pigmentationdrangelosmith
 
Topical corticosteroids
Topical corticosteroidsTopical corticosteroids
Topical corticosteroidsAjeet Singh
 
Skin Keratinization & Its Disorders
Skin Keratinization & Its DisordersSkin Keratinization & Its Disorders
Skin Keratinization & Its DisordersJerriton Brewin
 
Ageing and Geriatric dermatoses
Ageing and Geriatric dermatosesAgeing and Geriatric dermatoses
Ageing and Geriatric dermatosesManasa Janney
 
Dermatology emergencies grand rounds
Dermatology emergencies grand roundsDermatology emergencies grand rounds
Dermatology emergencies grand roundstonedcalves
 
Psoriasis evidence based treatment
Psoriasis evidence based treatmentPsoriasis evidence based treatment
Psoriasis evidence based treatmentDr Daulatram Dhaked
 
differentials of papules on face
differentials of papules on facedifferentials of papules on face
differentials of papules on faceMikhin Thomas
 
Dermo epidermal junction
Dermo epidermal junctionDermo epidermal junction
Dermo epidermal junctionRANJANDASH12
 
Eczema and dermatitis DERMATOLOGY
Eczema and dermatitis DERMATOLOGYEczema and dermatitis DERMATOLOGY
Eczema and dermatitis DERMATOLOGYTONY SCARIA
 
Disorders of Hyperpigmentation
Disorders of HyperpigmentationDisorders of Hyperpigmentation
Disorders of HyperpigmentationIbrahim Farag
 
Approach to photodermatoses
Approach to photodermatosesApproach to photodermatoses
Approach to photodermatosesDrYusraShabbir
 
Pityriasis rosea,lichenoides
Pityriasis rosea,lichenoidesPityriasis rosea,lichenoides
Pityriasis rosea,lichenoidesAjai Padamadathil
 

La actualidad más candente (20)

Psoriasis part2
Psoriasis part2Psoriasis part2
Psoriasis part2
 
Cyclosporine in dermatology
Cyclosporine in dermatologyCyclosporine in dermatology
Cyclosporine in dermatology
 
Skin and skin diseases
Skin and skin diseasesSkin and skin diseases
Skin and skin diseases
 
Topical Prepartions in dermatology
Topical Prepartions in dermatologyTopical Prepartions in dermatology
Topical Prepartions in dermatology
 
Psoriasis
Psoriasis Psoriasis
Psoriasis
 
Psoriasis part1
Psoriasis part1Psoriasis part1
Psoriasis part1
 
Basic Pathological Reactions of the Skin - Dr Zainab Almossalli
Basic Pathological Reactions of the Skin - Dr Zainab AlmossalliBasic Pathological Reactions of the Skin - Dr Zainab Almossalli
Basic Pathological Reactions of the Skin - Dr Zainab Almossalli
 
Disorders of pigmentation
Disorders of pigmentationDisorders of pigmentation
Disorders of pigmentation
 
Topical corticosteroids
Topical corticosteroidsTopical corticosteroids
Topical corticosteroids
 
Skin Keratinization & Its Disorders
Skin Keratinization & Its DisordersSkin Keratinization & Its Disorders
Skin Keratinization & Its Disorders
 
Ageing and Geriatric dermatoses
Ageing and Geriatric dermatosesAgeing and Geriatric dermatoses
Ageing and Geriatric dermatoses
 
Dermatology emergencies grand rounds
Dermatology emergencies grand roundsDermatology emergencies grand rounds
Dermatology emergencies grand rounds
 
Psoriasis evidence based treatment
Psoriasis evidence based treatmentPsoriasis evidence based treatment
Psoriasis evidence based treatment
 
differentials of papules on face
differentials of papules on facedifferentials of papules on face
differentials of papules on face
 
acne vulgaris
acne vulgarisacne vulgaris
acne vulgaris
 
Dermo epidermal junction
Dermo epidermal junctionDermo epidermal junction
Dermo epidermal junction
 
Eczema and dermatitis DERMATOLOGY
Eczema and dermatitis DERMATOLOGYEczema and dermatitis DERMATOLOGY
Eczema and dermatitis DERMATOLOGY
 
Disorders of Hyperpigmentation
Disorders of HyperpigmentationDisorders of Hyperpigmentation
Disorders of Hyperpigmentation
 
Approach to photodermatoses
Approach to photodermatosesApproach to photodermatoses
Approach to photodermatoses
 
Pityriasis rosea,lichenoides
Pityriasis rosea,lichenoidesPityriasis rosea,lichenoides
Pityriasis rosea,lichenoides
 

Destacado (20)

Analgesics
AnalgesicsAnalgesics
Analgesics
 
Presentation on dry granulation
Presentation on dry   granulationPresentation on dry   granulation
Presentation on dry granulation
 
Drug metabolism ppt
Drug metabolism pptDrug metabolism ppt
Drug metabolism ppt
 
Pharmaceutical granules
Pharmaceutical granulesPharmaceutical granules
Pharmaceutical granules
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
LAXATIVES
LAXATIVESLAXATIVES
LAXATIVES
 
Laxatives and Purgatives
Laxatives and PurgativesLaxatives and Purgatives
Laxatives and Purgatives
 
Analgesics kp
Analgesics kpAnalgesics kp
Analgesics kp
 
Narcotics and non narcotics analgesics
Narcotics and non narcotics analgesicsNarcotics and non narcotics analgesics
Narcotics and non narcotics analgesics
 
Pharmacokinetics: Lecture One
Pharmacokinetics: Lecture OnePharmacokinetics: Lecture One
Pharmacokinetics: Lecture One
 
Tablet coating
Tablet coating Tablet coating
Tablet coating
 
Presentation for Tablet Coating
Presentation for Tablet CoatingPresentation for Tablet Coating
Presentation for Tablet Coating
 
Coating Of Tablets
Coating Of TabletsCoating Of Tablets
Coating Of Tablets
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Granulation process and types of granulators
Granulation process and types of granulatorsGranulation process and types of granulators
Granulation process and types of granulators
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Granulation
GranulationGranulation
Granulation
 
Soft Gelatin Capsules
Soft Gelatin CapsulesSoft Gelatin Capsules
Soft Gelatin Capsules
 

Similar a Seminar principles of topical therapy

WHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptxWHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptxLutfiMK
 
WHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptxWHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptxLutfiMK
 
Restylane®️/Perlane®️ Injection Training Course Certification
Restylane®️/Perlane®️ Injection Training Course CertificationRestylane®️/Perlane®️ Injection Training Course Certification
Restylane®️/Perlane®️ Injection Training Course CertificationCosmetic Medical Training
 
Trasndermal Drug Delivery System
Trasndermal Drug Delivery SystemTrasndermal Drug Delivery System
Trasndermal Drug Delivery Systemashishmedatwal87
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.pptWolfram Bodenmüller
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.pptssuser8705f6
 
University of Limpopo B.Pharm 2: Pharmaceutics: dosage forms
University of Limpopo B.Pharm 2: Pharmaceutics: dosage formsUniversity of Limpopo B.Pharm 2: Pharmaceutics: dosage forms
University of Limpopo B.Pharm 2: Pharmaceutics: dosage formsThabangowen
 
Moisturizers An Essential Component in Eczema Management
Moisturizers An Essential Component in Eczema ManagementMoisturizers An Essential Component in Eczema Management
Moisturizers An Essential Component in Eczema ManagementMoch Kurniawan
 
SUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATORE
SUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATORESUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATORE
SUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATOREKMCH COLLEGE OF PHARMACY
 
Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasNEHA MALIK
 
A novel approach : transdermal gel
A novel approach : transdermal gelA novel approach : transdermal gel
A novel approach : transdermal gelJoko Rinanto
 
Transdemal dds : a review
Transdemal dds : a reviewTransdemal dds : a review
Transdemal dds : a reviewAdhikari Natraj
 
Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.
Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.
Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.Taj Pharma
 
Burns-Original.pptx
Burns-Original.pptxBurns-Original.pptx
Burns-Original.pptxssuser942c99
 
No px slides 78-end
No px  slides 78-endNo px  slides 78-end
No px slides 78-endRocky Hayes
 
Transdermal drug delivery system by MANSOORI MOHAMMAD SHOAIB.
Transdermal drug delivery system by  MANSOORI MOHAMMAD SHOAIB. Transdermal drug delivery system by  MANSOORI MOHAMMAD SHOAIB.
Transdermal drug delivery system by MANSOORI MOHAMMAD SHOAIB. Shoaib Khan
 

Similar a Seminar principles of topical therapy (20)

WHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptxWHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptx
 
WHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptxWHEN WE USE STEROID.pptx
WHEN WE USE STEROID.pptx
 
Restylane®️/Perlane®️ Injection Training Course Certification
Restylane®️/Perlane®️ Injection Training Course CertificationRestylane®️/Perlane®️ Injection Training Course Certification
Restylane®️/Perlane®️ Injection Training Course Certification
 
TDDS
TDDSTDDS
TDDS
 
Trasndermal Drug Delivery System
Trasndermal Drug Delivery SystemTrasndermal Drug Delivery System
Trasndermal Drug Delivery System
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
 
University of Limpopo B.Pharm 2: Pharmaceutics: dosage forms
University of Limpopo B.Pharm 2: Pharmaceutics: dosage formsUniversity of Limpopo B.Pharm 2: Pharmaceutics: dosage forms
University of Limpopo B.Pharm 2: Pharmaceutics: dosage forms
 
Moisturizers An Essential Component in Eczema Management
Moisturizers An Essential Component in Eczema ManagementMoisturizers An Essential Component in Eczema Management
Moisturizers An Essential Component in Eczema Management
 
SUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATORE
SUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATORESUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATORE
SUSTAIN RELEASE DOSAGE FORMS-KMCH COP, COIMBATORE
 
Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulas
 
A novel approach : transdermal gel
A novel approach : transdermal gelA novel approach : transdermal gel
A novel approach : transdermal gel
 
Transdemal dds : a review
Transdemal dds : a reviewTransdemal dds : a review
Transdemal dds : a review
 
Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.
Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.
Clobetasol propionate 0.05% cream pil, taj pharmaceuticals.
 
Burns-Original.pptx
Burns-Original.pptxBurns-Original.pptx
Burns-Original.pptx
 
Semisolid dosage form
Semisolid dosage formSemisolid dosage form
Semisolid dosage form
 
No px slides 78-end
No px  slides 78-endNo px  slides 78-end
No px slides 78-end
 
Transdermal drug delivery system by MANSOORI MOHAMMAD SHOAIB.
Transdermal drug delivery system by  MANSOORI MOHAMMAD SHOAIB. Transdermal drug delivery system by  MANSOORI MOHAMMAD SHOAIB.
Transdermal drug delivery system by MANSOORI MOHAMMAD SHOAIB.
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
Topical agents
Topical agentsTopical agents
Topical agents
 

Más de Dr Daulatram Dhaked (20)

Treponema pallidum tutorial
Treponema pallidum tutorial Treponema pallidum tutorial
Treponema pallidum tutorial
 
Resistant urticaria tutorial ppt.
Resistant urticaria tutorial ppt.Resistant urticaria tutorial ppt.
Resistant urticaria tutorial ppt.
 
Psoriatic arthropathy
Psoriatic arthropathyPsoriatic arthropathy
Psoriatic arthropathy
 
Physiotherapy in dermatology ppt
Physiotherapy in dermatology pptPhysiotherapy in dermatology ppt
Physiotherapy in dermatology ppt
 
Pruritus targated treatment- a look into future
Pruritus  targated treatment- a look into futurePruritus  targated treatment- a look into future
Pruritus targated treatment- a look into future
 
Ppt scar
Ppt scarPpt scar
Ppt scar
 
Methotrexate
MethotrexateMethotrexate
Methotrexate
 
Melasma treatment
Melasma treatmentMelasma treatment
Melasma treatment
 
Melanocyte culture technique
Melanocyte culture techniqueMelanocyte culture technique
Melanocyte culture technique
 
Leprosy nlep & currents trends
Leprosy nlep & currents trendsLeprosy nlep & currents trends
Leprosy nlep & currents trends
 
Isotretinoin in acne
Isotretinoin in acneIsotretinoin in acne
Isotretinoin in acne
 
Gonorrhoea
GonorrhoeaGonorrhoea
Gonorrhoea
 
Genital ulcer
Genital ulcerGenital ulcer
Genital ulcer
 
Female hair loss
Female hair lossFemale hair loss
Female hair loss
 
Dermal filler sminar
Dermal filler sminarDermal filler sminar
Dermal filler sminar
 
Dapsone, colchicine
Dapsone, colchicineDapsone, colchicine
Dapsone, colchicine
 
Cutaneous features of endocrine diseases
Cutaneous features of endocrine diseasesCutaneous features of endocrine diseases
Cutaneous features of endocrine diseases
 
Cutaneous pseudolymphoma
Cutaneous pseudolymphomaCutaneous pseudolymphoma
Cutaneous pseudolymphoma
 
Clinicl aproch to blistering dissorder
Clinicl aproch to blistering dissorderClinicl aproch to blistering dissorder
Clinicl aproch to blistering dissorder
 
Clinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions pptClinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions ppt
 

Último

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...PsychoTech Services
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 

Último (20)

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 

Seminar principles of topical therapy

  • 1. Seminar presentation Principles of Topical Therapy Moderator:- Dr. R. S. Meena
  • 2. • The skin has a surface area of 1.6-2 m2 • This area enables the enhancement of systemic treatment measures • An extensive region for the application and absorption of topical medications • The active ingredients penetrate the skin either via transepidermal or transfollicular pathways
  • 3. • Sensible topical drug therapy involves not only the selection of an appropriate agent, but also a thoughtful consideration of the areas of the body affected. • Basic principles1. State of the diseased skin(Pathologic changes) 2. Age of patient 3. Area of the body 4. Concentration of the drug 5. Type of vehicle (e.g., ointment, cream, lotion) 6. Method of application 7. A defined duration of use that both maximizes efficacy and minimizes adverse side effects.
  • 4. FACTORS THAT AFFECT ABSORPTION CUTANE OUS DRUG DELIVERY Therapeutic efficacy-relates to both its inherent potency and its ability to penetrate the skin. Percutaneous absorption necessitates passage through the stratum corneum, epidermis, papillary dermis, and into the bloodstream. Topical medicines generally have a poor total absorption . But it does not necessarily translate into low efficacy. Stratum Rate-limiting barrier to percutaneous drug delivery. Composed of Corneum ceramides, free fatty acids, and cholesterol in a 1:1:1 molar ratio and By weight 50%, 35 % and 15% respectively. Drug penetration, will vary depending on body site, due to its thickness. Diseased skin- Abraded or eczematized skin presents less of a barrier. Solvents, surfactants, and alcohols can denature the cornified layer and increase penetration Occlusio n Range from application under an airtight dressing such as vinyl gloves or plastic wrap, to occlusion with cotton gloves or socks at night for treatment of hands and feet, to application of a medication already impregnated into an airtight dressing, as seen in flurandrenolide (Cordran) tape. Greatest benefit-should hydrate the skin by immersion in water. It increased- both efficacy and side effects .
  • 5. • • • • • • • • • • • Regional Differences in Penetration in decreasing orders 1.Mucous membrane 2. Scrotum 3. Eyelids 4. Face 5.Chest and back 6.Upper arm and legs 7.Lower arm and legs 8.Dorsa of hand and feets 9.Palmer and planter skin 10.Nails
  • 6. Frequency of Application • Must be specified in order to maximize the response whilst avoiding side effects such as irritation. • Emollients should be applied frequently enough to maintain their physical effect. • Active preparations are usually applied just once or twice a day. • As a general rule, twice daily application of drugs such as corticosteroids or deltanoids is only marginally more effective than once daily application. • Increasing the interval between applications can be a useful method of gradually reducing the intensity of a treatment, especially when it is difficult to do so by using a lower concentration or less potent agent.
  • 7. Drug concentration • The concentration is usually written as a percentage representing the proportion of the formulation, by weight, which is the active constituent. • A concentration of 1% indicates that 1 g of drug will be contained in 100 g of the formulation. • 1% solution contains 1 g of drug in 100 ml of the formulation. • Abbreviations w/w (weight in weight) and w/v (weight in volume) are often employed to indicate which convention is being used. • Concentration of a solution is in ‘parts’; thus a 1 part in 1000 solution of potassium permanganate contains 1 g in 1 L of solution, which could be expressed as 0.1% (w/v).
  • 8. Quantity of Application • The total quantity to be dispensed should be specified and it is helpful to inform the patient how long the prescribed quantity is expected to last. • Estimates of the quantity of cream or ointment have varied. • In one study a range of 12–27 g (average 18 g) was required for applications by ‘trained operators’, whilst a range of 8–115 g (average 44 g) was required when the treatment was self administered. • In a more recent study, male patients treating themselves applied an average of 20 g of ointment, and females applied 17 g. • Quantity required for 1 week of once-daily application to the whole body would be approximately 140 g for males and 120 g for females.
  • 9. Quantities (g) of medication required for twice daily application to the entire body at various ages. Age Requirement Daily (g) 8 Weekly (g) 3 months 8 56 6months 10 67 12 months 12 84 18 months 13 93 2 years 14 95 3 years 16 112 4 years 19 135 5 years 20 140 7 years 25 172 10 years 30 210 12 years 37 256
  • 10. Approximate quantities (g) required for each application of Medication to different anatomical regions. Anatomical region Males Females Trunk (including buttocks) 6.6 5.8 One leg 2.9 2.5 One foot 0.9 0.7 One arm and forearm 1.7 1.3 One hand 0.6 0.5 Face, neck and ears 1.3 0.9 Whole body 20 17
  • 11. Fingertip unit- An approximate but practical measure of topical medication is the fingertip unit. •This is the quantity of ointment, extruded from a tube with a nozzle of 5 mm diameter (note that nozzles do vary somewhat), extending from the distal crease of the forefinger to ventral aspect of the fingertip. fingertip unit •This unit weighs approximately 0.49 g in males and 0.43 g in females and covers, on average, an area of approx 300 cm2. The fingertip unit.
  • 12. Fingertip units required for a single treatment of various regions in children and adults adapted from. The unit is measured using an adult finger. Age Face and One upper One lower Trunk neck limb limb Whole body 3–6 month 1 1 1.5 2.5 8.5 1–2 years 1.5 1.5 2 5 13.5 3–5 years 1.5 2 3 6.5 18 6–10 years 2 2.5 4.5 8.5 24.5 Adult 2.5 4.5 7.6 13.5 40
  • 13. Compliance • Generally, adherence to a treatment regimen is associated with female gender, employment, being married, and low prescription costs. • Lower adherence is seen for patients with extensive disease, and paradoxically, Disease on the face. • Furthermore, compliance is negatively affected by depression, which is common in people with chronic skin conditions and found in up to 20 percent of patients with psoriasis.
  • 14. Miscellaneous Factors • Vigorous rubbing or massaging of the drug -increases the surface area and blood supply to the area locally, augmenting systemic absorption . • Presence of hair follicles on a particular body site also enhances drug delivery with the Scalp and beard areas presenting less of a barrier when compared with the relatively Hairless body sites. • Skin of older individuals is poorly hydrated, with fewer hair follicles and therefore may impede drug delivery. • Reducing the particle size of the active ingredient increases its surface area-volume ratio, allowing for a greater solubility of the drug in its vehicle.
  • 15. CLASSIFICATION AND CLINICAL APPLICATION OF TOPICAL FORMULATIONS • The vehicle is the inactive part of a topical preparation that brings a drug into contact with the skin. • Beneficial non-specific effectsCooling, protective, emollient, occlusive, or astringent properties. • Functions optimally when it is stable both chemically and physically and does not inactivate the drug. • It also should be nonirritating, nonallergenic, cosmetically acceptable, and easy to use. • Additionally, the vehicle must release the drug into the pharmacologically important compartment of the skin. • Finally, the patient must accept using the vehicle or else compliance will be poor.
  • 16. Frequently employed constituents of vehicles Lipids Castor oil, Cetyl alcohol, Cocoa butter, Isopropyl myristate, Isopropyl palmitate, Lanolin, Liquid paraffin, Shea butter, Stearic acid, Stearyl alcohol, White soft paraffin (petrolatum) Emulsifiers Alkyl sulphates and sulphonates, Glyceryl monostearate, Lanolin and derivatives, Phosphoric acid esters, Polyethylene glycols, Polyvalent metallic soaps, Propylene glycol fatty acid esters, Quaternary ammonium cationic compounds, Sorbitan monolaurate, monopalmitate and mono-oleate, Triethanolamine oleate Humectants Gelatine, Glycerin, Propylene glycol, Pyrrolidone carboxylic acid, Sorbitol, Urea Penetration enhancers Azone, Dimethyl sulphoxide, Propylene glycol, Salicylic acid, Urea Preservative s Benzyl alcohol, Butylated hydroxyanisole, Butylated hydroxytoluene Chlorocresol, Edetic acid/disodium edetate, Hydroxybenzoates (parabens), Propylene glycol, Sodium metabisulphite, Sorbic acid/sorbates Solvents Acetone, Ethanol, Ether, Chloroform, Glycerin, Isopropyl alcohol Methanol, Propylene glycol, Water
  • 17. Powders Absorb moisture and decrease friction Used in the intertriginous areas and on the feet Eg. antifungals Contain zinc oxide eg. calamine (antiseptic and covering properties), talc (lubricating and drying properties), and stearate (improved adherence) Poultices Wet solid mass (cataplasm of particles, ) sometimes heated, that is applied to diseased skin Used as wound cleansers and absorptive agents in exudative lesions such as decubiti and leg ulcers. Historically, contained meal, herbs, plants, and seeds. Modern poultice often consists of porous beads of dextranomer. Ointments Semisolid preparations that spread easily. Protective, hydrating, Classified into five categories: and lubricating. Hydrocarbon bases, Absorption bases, Emulsions of water-in-oil, Emulsions of oil-in-water, and Water-soluble bases. Dermatologists commonly refer to the hydrocarbon bases and absorption bases as ointments and the water-in-oil/oil-in-water emulsion bases as creams. In pharmaceutical terms, all of these preparations are ointments.
  • 18. HYDR0CARB0N BASES (oleaginous bases) Composed of a mixture of hydrocarbons of varying molecular weights, m.c. petrolatum Greasy and can stain clothing. stable and do not contain preservatives. not used for watersoluble drugs. silicon ointments are composed of alternating oxygen and silicon atoms bonded to organic groups, such as phenyl or methyl, and are excellent skin protectants. ABSORPTI0N BASES Contain hydrophilic substances that allow for the absorption of water-soluble drugs. Lubricating and hydrophilic, can form emulsions. Function as emollients and protectants Greasy but easier to remove, do not contain water. Eg. anhydrous lanolin and hydrophilic petrolatum.
  • 19. CREAMS( WATERIN-0IL EMULSIO N) By definition, contains <25% water, with oil being the dispersion medium. two-phase systems may separate unless shaken Less greasy, spread easily, and provide a protective film of oil, slow evaporation of the water phase provides a cooling effect Emulsifier( or surfactant) is soluble in both phases and surrounds the dispersed drops to prevent their coalescence. Preservatives are frequently added to increase the emulsion's shelf life. Eg. surfactants- sodium lauryl sulfate, the quaternary ammonium Compounds, Spans( sorbitan fatty acid esters), and Tweens (polyoxyethyiene sorbian fatty acid esters). Oil-inwater Emulsion s Contains >31 % water. Contain preservatives, such as the parabens, to inhibit the growth of molds. Spread very easily, are water washable and less greasy, and are easily removed from the skin and clothing. Contain a humectant (an agent that draws moisture into the skin), such as glycerin, propylene glycol, or polyethylene glycol(PEG), to prevent the cream from drying out. oil phase may contain either cetyl or stearyl alcohol (paraffin alcohols) to impart a stability and velvety smooth feel upon application to the skin.
  • 20. Water- Consist either primarily Water soluble, require no soluble or completely of various PEGs. preservative bases Depending on their M.W., PEGs are either liquid (eg. PEG 400) or solid (PEG 4000). Gels additives. nonstaining, greaseless, and easiiy washed off of the skin Made from watersoluble bases by formulating water, propylene glycol, and/or PEGs with a cellulose derivative or carbopol. Newer gel contain the humectant glycerin, the emollient dimethicone, or the viscoelastic polysaccharide hyaluronic acid Clear and ease of both application and removal. Easy to use on the hair-bearing body sites It will be useful in scenarios where the practitioner desires a high surface concentration and low percutaneous absorption of the drug. e.g. topical antifungal and antibiotics (mupirocin). They lack any protective or emollient properties. If they contain high concentrations of alcohol or propylene glycol, they tend to be drying or cause stinging. Gels require preservatives. After application the aqueous or alcoholic component evaporates, and the drug is deposited in a concentrated form.
  • 21. Pastes High concentrations of powders (up to 50 %) into an ointment such as a hydrocarbon base or a water-in-oil emulsion Must be insoluble in the ointment. Stiffer than the original ointment. Commonly used are zinc oxide, starch, calcium carbonate, and talc. Solution Dissolution of two or Liquid vehicle may be more substances into aqueous, homogenous clarity hydroalcoholic, or non-aqueous (alcohol, oils, or propylene glycol). Liniment s Non-aqueous solutions of drugs in oil or alcoholic solutions of soap. Function- localize the effect of a drug that may be staining or irritating (i.e. anthralin). Impermeable barriers that serve as protectants or sunblocks. Less greasy than ointments, more drying, and less occlusive. Aqueous solution- aluminum acetate or Burow's solution. Hydroalcoholic solution with 50% alcohol is called a tincture. Base of oil or soap Used as counterirritants, facilitates application astringents, antipruritics, to the skin with emollients, and analgesics. rubbing or massage.
  • 22. Coliodion Non-aqueous solution Flexible collodions have added castor oil of pyroxylin in a and camphor and are used, eg. to deliver mixture with ether and 10% salicylic acid as a keratolytic agent. ethanol applied to the skin with a soft brush Suspension Two-phase system or Lotion consisting of a finely divided, insoluble drug dispersed into a liquid in a concentration of up to 20%. Eg. calamine lotion, steroid lotions, and emollients containing urea or lactic acid easier to apply and allow for uniform coating of the affected area, and are often the favorite preparation in treating children. more drying than ointments. Shake lotions Application of shake lotions effectively dries and cools wet and weeping skin. consist of zinc oxide, talc, calamine, glycerol, alcohol, and water, to which specific drugs and stabilizers may be added. Powder is added to Lotions to increase the surface area of evaporation
  • 23. Aerosols Formulating the drug in a solution within a pure propellant. Propellant is a blend of nonpolar hydrocarbons. Used to deliver drugs formulated as solutions, suspensions, emulsions, powders, and semisolids. applied to abraded or eczematized skin, aerosols lack the irritation of other formulations. Aerosol foams Contains the drug within an emulsion formulated with a foaming agent(a surfactant), A solvent system (such as water and ethanol), and a propellant. Used to deliver corticosteroids such as betamethasone valerate and clobetasol propionate. On application, a foam lattice forms transiently until it is broken by both the heat of the skin and the heat of rubbing the foam onto the skin. Thickening Increase the viscosity of agents products or suspend ingredients in a formulation Eg. beeswax and carbomers. Addition to functioning as an ointment vehicle, petrolatum may be added to an emulsion to increase its viscosity. Ingredient ay have a therapeutic effect as well as acting as part of a vehicle.
  • 24.
  • 25. Stabilizers • Non-therapeutic ingredients and include the preservatives, antioxidants, and chelating agents. • Preservatives protect the formulation from microbial growth. • The ideal preservative is effective at a low concentration against a broad spectrum of organisms, nonsensitizing, odor free, color free, stable, and inexpensive. • Unfortunately, the ideal preservative does not exist.
  • 26. • The parabens are the most frequent added preservatives, and are active against molds, fungi, and yeasts, but less effective against bacteria. • Alternative agents include the halogenated phenols, benzoic acid, sodium benzoate, formaldehyde, the formaldehyde-releasing agents, and previously, thimerosal. • Most commonly used preservatives may act as contact sensitizers.
  • 27. • Antioxidants or preservatives prevent the drug or vehicle from degrading via oxidation. • Examples include butylated hydroxyanisole and burylated hydroxytoluene, used in oils and fats. • Ascorbic acid, sulfites, and sulfur-containing amino acids are used in water soluble phases. • Chelating agents, such as sodium EDTA and citric acid, work synergistically with antioxidants by complexing heavy metals in aqueous phases.
  • 28. When do we use topical treatment? • If a patient has a skin disorder covering < 30% of body, the topical medication may be considered.
  • 29. Choice of vehicles • Three main determinants to choose the right vehicle are: Patient’s skin type Degree of acuity of the disease Nature of the lesions
  • 30. Choice of vehicles • Skin type: About 50% of individuals have oily skin or seborrhea. • They do better with creams, lotions, or shake lotions while the ones with dry skin do better with ointments or pastes. • Degree of acuity: Acute inflammatory processes are best treted with creams or lotions. • If the lesions are weeping, shake lotions are fine.
  • 31. Choice of vehicles for different lesions
  • 32. Topical agents Ⅰ Classification Action Smooth agents reduce friction avoid stimulation Antimycotics Antiseptics Drug Concentration(%) calamine talc zinc oxide kill or inhibition sulphur Glacial Acetic Acid benzonic acid salicylic acid clotrimazole Miconazole Terbinafine kill or inhibition boracic acid potassium permanganate Neomycin revanol 10-15 10-70 20-50 5—10 5--30 6--12 5--10 2---3 2 1 3---4 1/2000 1/5000 0.5-1 0.1
  • 33. Topical agents Ⅱ Classification Antipruritics Action narcotism、 dimimish inflammation stop itchness Drug Concentration(%) cool mint carbolic acid bendazolecain dexamethasone triamcinolone Keratoplastics promote normal keratosis pityrol shrink blood vessel coal tar reduce effusion and resorcinol inflammatory infiltration salicylic acid 1---5 0.2-3 1---2 3---5 0.025 0.025 3---5 5--40 2---5 3
  • 34. Topical agents Ⅲ Classification Action Concentration(%) keratolytics Drug hyperkeratosis salicylic acid make keratinocytes loose resorcinol separate and fall off Glacial Acetic Acid urea Caustics remove granulation carbolic acid tissue and neoplasm Glacial Acetic Acid salicylic acid trichloroaceticacid sunscreen absorb or prevent Titanium dioxide ultraviolet radiation depigmenting reduce pigmentation Hydroquinone agents Azelaic Acid 6--15 6--15 10-30 20-40 pure >30 >20 >30 5 3 20
  • 35. Topical corticosteroids Potency Ultra high Class Formulation II Clobetasol propionate Cream, 0.05% Diflorasone diacetate High I Topical corticosteroid Ointment, 0.05% Amcinonide Ointment, 0.1% Betamethasone dipropionate Ointment, 0.05% Desoximetasone Fluocinonide Cream, ointment or gel, 0.05% Halcinonide III Cream or ointment, 0.025% Cream, 0.1% Betamethasone dipropionate Cream, 0.05% Betamethasone valerate Ointment, 0.1% Diflorasone diacetate Cream, 0.05% Triamcinolone acetonide Ointment, 0.1%
  • 36. Moderate IV Ointment, 0.2% Triamcinolone acetonide Cream, 0.1% Betamethasone dipropionate Lotion, 0.02% Betamethasone valerate Cream, 0.1% Fluocinolone acetonide Cream, 0.025% Fludroxycortide Cream, 0.05% Hydrocortisone butyrate Cream, 0.1% Hydrocortisone valerate Cream, 0.2% Betamethasone valerate Lotion, 0.05% Desonide Cream, 0.05% Fluocinolone acetonide VII Ointment, 0.05% Hydrocortisone valerate VI Ointment, 0.025% Fludroxycortide Low Cream, 0.05% Fluocinolone acetonide V Desoximetasone Solution, 0.01% Dexamethasone sodium phosphate Cream, 0.1% Hydrocortisone acetate Cream, 1% Methylprednisolone acetate Cream, 0.25%
  • 37.
  • 38. Side effects of topical corticosteroids • • • • • Epidermis : Atrophy Hair follicles: Steroid acne Dermis: Atrophy, striae Pigmentation: Hypopigmentation Vessels: Erythema, telangiectases
  • 39. Hazards associated with topical treatment • M.C. - Localized irritant or allergic reactions. • This can be minimized by applying treatment at the optimal concentration and treatment intervals and by selection of the correct vehicle. • Sensitization is more difficult to anticipate and to prevent. • Contact allergy can develop not only to the active medicament but also to constituents of the vehicle. • Almost any component may sensitize; notable examples include ethylenediamine, propylene glycol, emulsifiers, sorbic acid , cetyl and stearyl alcohols and fragrances. • Patients with chronic venous eczema or leg ulcers appear to be particularly susceptible.
  • 40. Systemic Side Effects • Rare • Absorption varies very considerably depending on the region of skin being treated. • Occlusion greatly enhances absorption. • Systemic exposure can be greater than expected in children due to their relatively high ratio of skin surface to body mass. • In the elderly, penetration of drugs may be increased as a result of changes in the structure of the skin. • This effect is most pronounced in drugs which are most hydrophilic . • Inflammation of the skin impairs barrier function and significantly increases drug absorption. • This is especially significant in the erythrodermic patient
  • 42. Topical agents • • • • • • • • • Keratolytic agents Cytotatic agents: Podophyllin, 5-fluorouracil Retinoids Antibiotics, antifungals, antiviral agents Corticosteroids Combination products Tacrolimus, pimecrolimus Nonsteroidal antiinflammatory agents Sunscreens
  • 43. • Class I (weakest): Hydrocortisone, prednisolone • Class II: Methylprednisolone aceponate, triamcinolone • Class III: Betamethasone 17-valerate • Class IV (strongest): Clobetasol 17-propionate
  • 44. Formulation Ⅰ Dosage form Powder Solution Lotion Cream component action indications drug put into zinc oxide, talc and stearate Absorb moisture acute and subacute inflammation and decrease friction but no effusion astringency, protection, cooling Used in the intertriginous areas and on the feet Eg. antifungals liquid and soluble drug cooling, clear raw surface 、 acute inflammation dissolution of two or reduce inflammation with lots of effusion more substances into eg. Aqueous solutionhomogenous clarity aluminum acetate or Burrow’s solution powder and liquid protection, cooling acute and subacute mixture- two phase reduce inflammation inflammation without system (conc. Up to 20%) astringency, more drying effusion, favourite for Eg. Calamine , steroid lotions, children emolient containing urea or lactic acid consisting of aqueous protection、lubrication subacute or chronic and oily components intenerate crust inflammation ,pruritus O/W emulsion being readiy reduce inflammation diluted with water,W/O emulsion with oil Solution
  • 45. Formulation Ⅰ Dosage form Gel • component action indications Propanediol gelatin protection, lubrication subacute or chronic of organic polymer reduce inflammation inflammation ,pruritus drug Clear and ease of both application and removal. Easy to use on the hair-bearing body sites
  • 46. Fomulation Ⅱ action dosage form component Paste indications cream including protection、astringency 25%-50% powder intenerate crust diminish inflammation ointment vehicle with vaseline or lanolin strong action of lubrication、penetration intenerate crust tincture resolve or steep diminish inflammation drug by alcohol antipruritic subacute inflammation, scar,erosion chronic inflammation ulcer chronic inflammation sterilization pruritus
  • 47. Fomulation Ⅱ dosage form Plastics component action organic menstruum and aqueous solution contain macromolecule compound or film agent indications protection strong percutaneous strong percutaneous action chronic inflammation